David George's Stock Ratings

Baird Analyst

David George is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 09/07/2024

Overall Average Return

17.3%

Smart Score

74.4%

Overall Average Return Percentile

76th

Number of Ratings

75
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Breaking Down Humana: 11 Analysts Share Their Views
Centene Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
Critical Insights From Jabil Analyst Ratings: What You Need To Know
NetApp Analysts Boost Their Forecasts After Upbeat Earnings
Last Big Cannabis Event Before The Election: 10 Reasons To Attend
Join industry leaders at the 2024 Benzinga Cannabis Capital Conference in Chicago. Don't miss insights, networking & opportunities this fall.
Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election
Join cannabis industry leaders at Benzinga's Fall Conference in Chicago. Keynotes, networking, and legalization insights.
Cannabis Co. Verano Completes $105M Acquisition Of Arizona, Virginia Operations From Leading US Operator
A Glimpse Into The Expert Outlook On Zions Bancorp Through 13 Analysts
CEO Shake-Ups At Canopy, Curaleaf And Recent Top Exec And Board Changes In Cannabis And Psychedelics
In late July, nearly three months after New York Governor Kathy Hochul fired Chris Alexander, the former head of the state's Office of Cannabis Management (OCM), following an internal review, a series of high-level departures made headlines.Connecticut Social Equity Council (SEC), which manages social equity activity for the state's recreational marijuana market, got a new executive director earlier this month. Brandon McGee, who previously worked on Gov. Ned Lamont's reelection in 2022,  replaced Ginne-Rae Clay, reported Marijuana Business Daily citing CT Insider.Canopy Growth Corporation and Curaleaf Holdings, Inc. announced CEO shake-ups.
In-Depth Examination Of 11 Analyst Recommendations For Teladoc Health
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free